Peritoneovenous shunts in malignant ascites
- PMID: 2996864
- DOI: 10.1007/BF01315609
Peritoneovenous shunts in malignant ascites
Abstract
A 51-year-old woman with malignant ascites secondary to hepatocellular carcinoma had a peritoneovenous (LeVeen) shunt inserted with effective control of ascites and amelioration of symptoms. The results of 12 recent series evaluating the efficacy of peritoneovenous shunts in the treatment of 198 patients with malignant ascites were reviewed. Peritoneovenous shunts effectively controlled malignant ascites in 77% of patients. Complications occurred in 25%, although the majority of these were related to shunt occlusion and transient congestive heart failure.
Similar articles
-
Denver peritoneovenous shunts for the management of malignant ascites: a review of the literature in the post LeVeen Era.Am Surg. 2011 Aug;77(8):1070-5. doi: 10.1177/000313481107700830. Am Surg. 2011. PMID: 21944526 Review.
-
Peritoneovenous shunting for malignant ascites.Wis Med J. 1988 Jun;87(6):31-3. Wis Med J. 1988. PMID: 2840780 No abstract available.
-
Peritoneovenous shunt in malignant ascites. The Bordet Institute experience from 1975-1998.Hepatogastroenterology. 2000 Sep-Oct;47(35):1322-4. Hepatogastroenterology. 2000. PMID: 11100342
-
Peritoneovenous shunts palliate malignant ascites.Am J Surg. 1989 Dec;158(6):598-601. doi: 10.1016/0002-9610(89)90202-x. Am J Surg. 1989. PMID: 2480068
-
The peritoneovenous shunt: expectations and reality.Am J Gastroenterol. 1990 Aug;85(8):917-29. Am J Gastroenterol. 1990. PMID: 2197858 Review.
Cited by
-
[Peritoneovenous shunt in the treatment of therapy-refractory ascites].Langenbecks Arch Chir. 1988;373(1):47-56. doi: 10.1007/BF01263261. Langenbecks Arch Chir. 1988. PMID: 3282133 Review. German. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Medical